MCAM and breast carcinoma: The CD146-positive CAFs have been proved to maintain ER expression in ER positive breast cancer cells and remain estrogen responsive and sensitivity to tamoxifen, while CD146-negative CAFs can inhibit the response of cancer cells to tamoxifen and lead to poor treatment outcomes [53].